The tortoise and the hare ... and the unicorn

Where will private market unicorns finish in the race between the public market tortoises and hares? ApeVue looks at data from the opaque private markets for answers.

Unicorn coins money

The old fable of the tortoise and the hare teaches us that slow and steady wins the race, and this holds true year-to-date when looking broadly across the public and private equity markets. Comparing between their animal likenesses, the “creep” of tortoises might be represented by the Dow Jones Industrial Average 30, the “drove” of hares could be seen as the Nasdaq, and the “blessing” of unicorns entering the race would be represented by the ApeVue50. 

  !function(e,i,n,s){var t="InfogramEmbeds

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

In Absentia: Remembering Sandra Villena and finding her killer

Sandra Villena, a 32-year-old market data professional on the rise, was murdered while on vacation in October 2022. Nearly a year later, her friends and family are still seeking justice, while they learn how to live with the absence that now fills their lives.

In Absentia: Recordando a Sandra Villena y en búsqueda de su Asesino

Sandra Villena, una profesional de datos de mercado de 32 años con gran promesa, fue asesinada mientras estaba de vacaciones en octubre de 2022. Casi un año después, sus amigos y familiares todavía buscan justicia, mientras aprenden a vivir con la ausencia que ahora llena sus vidas.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here